High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithinchoesteryl acyltransferase

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Nature Medicine

• Publication date

  1997-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/NM0797-744PMID 9212100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lecithin:Cholesterol Acyltransferase Overexpression Generates Hyperalpha-lipoproteinemia and a Nonatherogenic Lipoprotein Pattern in Transgenic Rabbits (*)

  1996cited by this paper
• Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

  1996cited by this paper
• Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

  1996cited by this paper
• Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice (*)

  1995cited by this paper
• Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma.

  1995cited by this paper
• Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.

  1995cited by this paper
• Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.

  1995cited by this paper
• Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG.

  1995cited by this paper
• In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene (*)

  1995cited by this paper
• Nonlinear effects of noise on phase-locked cochlear-nerve responses to sinusoidal stimuli.

  1995cited by this paper
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• The role of apolipoprotein A‐l-containing lipoproteins in atherosclerosis

  1994cited by this paper
• A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer.

  1994cited by this paper
• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

  1994cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper
• Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma.

  1993cited by this paper
• Protein composition determines the anti-atherogenic properties of HDL in transgenic mice

  1993cited by this paper
• Plasma cholesteryl ester transfer protein.

  1993cited by this paper
• Very low high-density lipoproteins without coronary atherosclerosis.

  1993cited by this paper
• Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among plasma apo B-containing lipoprotein subpopulations.

  1993cited by this paper
• Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.

  1993cited by this paper
• Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction

  1992cited by this paper
• Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

  1992cited by this paper
• Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI

  1991cited by this paper
• Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice.

  1990cited by this paper
• Synthetic low and high fat diets for the study of atherosclerosis in the mouse.

  1990cited by this paper
• Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

  1990cited by this paper
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.

  1990cited by this paper
• Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived choleste

  1989cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

  1989cited by this paper
• Isolation of plasma lipoproteins by a combination of differential and density gradient ultracentrifugation

  1988cited by this paper
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles.

  1987cited by this paper
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

  1987cited by this paper
• Quantitative assessment of atherosclerotic lesions in mice.

  1987cited by this paper
• Isolation, characterization, and assay of plasma lipid transfer proteins.

  1986cited by this paper
• Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression.

  1986cited by this paper
• Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man.

  1985cited by this paper
• Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit

  1985cited by this paper
• Clinical and metabolic aspects of high-density lipoproteins

  1984cited by this paper
• Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity.

  1982cited by this paper
• Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase.

  1981cited by this paper
• A plasma inhibitor of triglyceride and cholesteryl ester transfer activities.

  1981cited by this paper
• Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

  1970cited by this paper
• The plasma lecithins:cholesterol acyltransferase reaction.

  1968cited by this paper

• Lymphatic uptake and pharmacokinetics of lipid conjugated brush PEG polymers is altered by interactions with albumin and lipoproteins

  2025cites this paper
• High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels

  2025cites this paper
• Effects of Administration of Recombinant Human Lecithin-Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans

  2023cites this paper
• Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs

  2023cites this paper
• Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs

  2023cites this paper
• Arctic introgression and chromatin regulation facilitated rapid Qinghai-Tibet Plateau colonization by an avian predator

  2022cites this paper
• Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives

  2022cites this paper
• LCAT- targeted therapies: Progress, failures and future.

  2022cites this paper
• High‐density lipoprotein cholesterol levels are associated with major adverse cardiovascular events in male but not female patients with hypertension

  2021influential citation
• Controversial Role of Lecithin:Cholesterol Acyltransferase in the Development of Atherosclerosis: New Insights From an LCAT Activator.

  2021cites this paper
• Correction of Familial LCAT Deficiency by AAV-hLCAT Prevents Renal Injury and Atherosclerosis in Hamsters—Brief Report

  2021cites this paper
• The Role of LCAT in Atherosclerosis

  2020cites this paper
• Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models

  2020cites this paper
• Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress—Brief Report

  2020cites this paper
• Chronic Arsenic Exposure Induces Oxidative Stress and Perturbs Serum Lysolipids and Fecal Unsaturated Fatty Acid Metabolism.

  2019cites this paper
• Lipoproteins in Atherosclerosis Process.

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Insulin Regulation of Reverse Cholesterol Transport

  2019cites this paper
• The role of cholesteryl ester transfer protein TaqIB polymorphism in young atherosclerotic heart disease

  2019cites this paper
• Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.

  2018cites this paper
• FoxO transcription factors are required for hepatic HDL cholesterol clearance

  2018cites this paper
• CETP Inhibition Improves HDL Function but Leads to Fatty Liver and Insulin Resistance in CETP-Expressing Transgenic Mice on a High-Fat Diet

  2018cites this paper
• Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis.

  2017cites this paper
• Steryl ester synthesis, storage and hydrolysis: A contribution to sterol homeostasis.

  2017cites this paper
• HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics

  2017cites this paper
• The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging.

  2017cites this paper
• Avaliação da aterosclerose subclínica em portadores de HDL-colesterol marcadamente elevado

  2016cites this paper
• The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors

  2016cites this paper
• Role of LCAT in Atherosclerosis.

  2016cites this paper
• A meta-analytic evaluation of cholesteryl ester transfer protein (CETP) C-629A polymorphism in association with coronary heart disease risk and lipid changes

  2016cites this paper
• Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression.

  2016cites this paper
• Role of LCAT activity changes in atherosclerosis risk

  2016cites this paper
• Mechanism and Physiologic Significance of the Suppression of Cholesterol Esterification in Human Interstitial Fluid

  2016cites this paper
• Estudio de la contribución de las células endoteliales progenitoras y las partículas de colesterol HDL en los mecanismos de daño y reparación vascular en pacientes infectados por VIH

  2016cites this paper
• High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis

  2016cites this paper
• Dysfunctional HDL and atherosclerotic cardiovascular disease

  2016cites this paper
• Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism*

  2015cites this paper
• Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.

  2015cites this paper
• Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL.

  2015cites this paper
• High Density Lipoprotein Therapies—Then and Now

  2015cites this paper
• The Effect of Natural LCAT Mutations on the Biogenesis of HDL.

  2015cites this paper
• Prevention and treatment of atherosclerotic vascular disease: Hypolipidemic agents

  2015cites this paper
• Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice[S]

  2015cites this paper
• Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice

  2015cites this paper
• Exploring Genetically Modified Animals for Development of New Atherosclerosis Treatments in NHLBI

  2014cites this paper
• Mendelian Disorders of High-Density Lipoprotein Metabolism

  2014cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• Role of Lecithin

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) HDL cholesterol : atherosclerosis and beyond

  2013cites this paper
• Tissue-specific role of ATP binding cassette transporter A1 in atherogenesis

  2013cites this paper
• Etude de la capacité d'inhibition de l'apolipoprotéine C1 sur l'activité de la protéine de transfert des esters de cholestérol chez des patients coronariens normolipidémiques et hyperlipidémiques et chez des patients diabétiques

  2013cites this paper
• The two faces of high density lipoprotein: oxidized HDL elicits pro-atherogenic response in Human monocyte-macrophages

  2013cites this paper
• Increased Serum Cholesterol Esterification Rates Predict Coronary Heart Disease and Sudden Death in a General Population

  2013cites this paper
• High-density lipoproteins: a consensus statement from the National Lipid Association.

  2013cites this paper
• Recombinant human lecithin‐cholesterol acyltransferase Fc fusion: Analysis of N‐ and O‐linked glycans and identification and elimination of a xylose‐based O‐linked tetrasaccharide core in the linker region

  2013cites this paper
• The role of lysosomal acid lipase in regulation of the ATP-binding cassette transporter A1, high density lipoprotein and reverse cholesterol transport

  2013cites this paper
• Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

  2012cites this paper
• Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

  2012cites this paper
• DEFINING THE AFRICAN GREEN MONKEY (CHLOROCEBUS AETHIOPS): EXPRESSION BEHAVIOUR OF SELECTED LIPID METABOLISM GENES IN RESPONSE TO NIACIN

  2012cites this paper
• The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.

  2012cites this paper
• Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice.

  2012cites this paper
• The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?

  2012cites this paper
• Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

  2012cites this paper
• Lecithin-cholesterol acyltransferase : old friend or foe in atherosclerosis ?

  2012cites this paper
• Lecithin:Cholesterol Acyltransferase Deficiency Protects against Cholesterol-induced Hepatic Endoplasmic Reticulum Stress in Mice*

  2012cites this paper
• Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters.

  2012cites this paper
• Low High-Density Lipoprotein Cholesterol

  2012cites this paper
• The thienotriazolodiazepine Ro 11‐1464 increases plasma apoA‐I and promotes reverse cholesterol transport in human apoA‐I transgenic mice

  2011cites this paper
• Low levels of high-density lipoprotein cholesterol due to lecithin:cholesterol acyltransferase mutations increase carotid atherosclerosis.

  2011cites this paper
• Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?

  2011cites this paper
• AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/− Mice

  2011cites this paper
• Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis.

  2011cites this paper
• Effect of Recombinant Human Lecithin Cholesterol Acyltransferase Infusion on Lipoprotein Metabolism in Mice

  2010cites this paper
• The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

  2010cites this paper
• Lecithin:cholesterol acyltransferase and vascular disease

  2010cites this paper
• Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.

  2010cites this paper
• Métabolisme des lipides et des lipoprotéines chez l'homme

  2010cites this paper
• Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.

  2010cites this paper
• High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis.

  2010cites this paper
• Chapitre 3 – Biologie Vasculaire

  2010cites this paper
• Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

  2010cites this paper
• Gene therapy to improve high-density lipoprotein metabolism and function.

  2010cites this paper
• Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.

  2009cites this paper
• Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptides.

  2009cites this paper
• Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.

  2009cites this paper
• Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo

  2009cites this paper
• Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children.

  2009cites this paper
• An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration

  2009cites this paper
• The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008.

  2009cites this paper
• Improving cardiovascular disease prevention : from risk assessment to novel therapy

  2009cites this paper
• Protein and cell therapy for lecithin-cholesterol acyltransferase (LCAT) deficiency

  2009cites this paper
• Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.

  2009influential citation
• Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions

  2009cites this paper
• Dysfunctional high-density lipoprotein

  2009cites this paper
• Human Plasma Lipoprotein Metabolism

  2009cites this paper
• The Effect of Herbal-acupuncture with Moutan Cortex Radicis Extract

  2009cites this paper
• Changing paradigm in HDL metabolism and cellular effects

  2009cites this paper
• Current and emerging paradigms in the therapeutic management of atherosclerosis

  2008cites this paper
• A Study on the Effect of Herbal-acupuncture with HK-1000 Solution on Hyperlipidemia and Arteriosclerosis Induced Rats

  2008cites this paper